Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

McGill University

$778,857.00

The PRL-CNNM-Magnesium cascade, a new paradigm in oncogenesis.

EF 2014-15

Résumé
The PRL proteins have been found elevated in most cancers and in metastasis. This proposal investigates the function of these proteins in the process of cancer formation, proliferation and dissemination. Recently, we obtained exciting findings that the PRLs are associated to magnesium transporters in cancer cells named CNNMs. Through their actions they induce an increase in energy production by the tumour cells allowing them to maintain the high metabolic growth and need for their metastatic property. As we showed that removal or inhibition of this PRL gene leads to a major reduction in tumour formation we desire to study in details how this energy increase is induced by these genes in cancer cells. This proposal will thus characterize the biology of this novel mechanism and identify specific ways by which new anti-cancer therapeutics could be developed.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
323312
Name
Tremblay Michel L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Biology & Therapeutics
Projecttitle
The PRL-CNNM-Magnesium cascade, a new paradigm in oncogenesis.
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$778,857
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cancer; Cancer Genomics; Cnnm; Crispr; Embryonic Stem Cell; Gene Expression; Growth Regulation; Magnesium; Metastasis; Ptp4a
Abstract
The PRL proteins have been found elevated in most cancers and in metastasis. This proposal investigates the function of these proteins in the process of cancer formation, proliferation and dissemination. Recently, we obtained exciting findings that the PRLs are associated to magnesium transporters in cancer cells named CNNMs. Through their actions they induce an increase in energy production by the tumour cells allowing them to maintain the high metabolic growth and need for their metastatic property. As we showed that removal or inhibition of this PRL gene leads to a major reduction in tumour formation we desire to study in details how this energy increase is induced by these genes in cancer cells. This proposal will thus characterize the biology of this novel mechanism and identify specific ways by which new anti-cancer therapeutics could be developed.
Competitiondate
201503
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Tremblay, Michel L
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $778,857~ $0~